Fresenius Medical Care AG & Co. KGaA is a leading global provider of products and services for individuals with renal diseases, specifically focusing on chronic kidney failure. This German-based healt... Fresenius Medical Care AG & Co. KGaA is a leading global provider of products and services for individuals with renal diseases, specifically focusing on chronic kidney failure. This German-based healthcare company operates dialysis clinics and provides dialysis care services to numerous patients worldwide. Its primary function is to enhance the quality of life for patients through its extensive network of dialysis clinics, as well as to supply dialysis-related products and technologies to healthcare facilities.
Fresenius Medical Care impacts key sectors such as healthcare and pharmaceuticals, playing a pivotal role in innovations related to dialysis treatment and kidney care. The company also engages in ongoing research and development to improve patient outcomes and expand its treatment options. In the financial markets, it holds a significant position within the dialysis service industry due to its expansive operations and comprehensive care solutions, making it a critical player in the global healthcare system. With its headquarters in Bad Homburg, Germany, Fresenius Medical Care continues to provide essential treatment solutions that cater to the growing global demand for dialysis services.
In 2024, Fresenius Medical Care was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Fresenius Medical Care has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Fresenius Medical Care are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Turnover
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
1.2 PPC - Manufacture of medicinal products
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Opex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
1.2 PPC - Manufacture of medicinal products
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
7.5 CCM/CCA - Installation, maintenance and repair of instruments and devices for measuring, regulation and controlling energy performance of buildings
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Capex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
1.2 PPC - Manufacture of medicinal products
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
7.5 CCM/CCA - Installation, maintenance and repair of instruments and devices for measuring, regulation and controlling energy performance of buildings
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Fresenius Medical Care’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to 2021.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Fresenius Medical Care’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fresenius Medical Care’s data sources below and access millions more through our Disclosure Search.
a. Fresenius Medical Care's Annual Report 2024
b. Fresenius Medical Care's Annual Report 2023
c. Fresenius Medical Care's Annual Report 2022
d. Fresenius Medical Care's ESG Data Spreadsheet 2022
Insights into Fresenius Medical Care's Revenues from Sustainable Activities
In 2024, Fresenius Medical Care reported EU Taxonomy-eligible revenues of EUR 302.10 million, representing 1.6% of its total turnover. Of this amount, EUR 302.10 million of Fresenius Medical Care's revenues was classified as EU Taxonomy-aligned, indicating that 1.6% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
How much of Fresenius Medical Care's revenue is eligible under the EU Taxonomy?
In 2024, Fresenius Medical Care reported that EUR 302.10 million of its revenue was eligible under the EU Taxonomy, representing 1.6% of the company's total turnover. Of this amount, EUR 302.10 million (1.6% of total revenue) was classified as Taxonomy-aligned. This means that 0% of Fresenius Medical Care's revenue is eligible but not aligned, indicating that these activities did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards.a
How much of Fresenius Medical Care's eligible revenue is aligned with the EU Taxonomy?
In 2024, Fresenius Medical Care reported that EUR 302.10 million of its revenue was aligned under the EU Taxonomy, representing 1.6% of its total turnover.a
This low alignment highlights either a limited focus on green activities or early-stage adoption of sustainability frameworks, underscoring opportunities for further alignment with EU climate objectives.
Fresenius Medical Care's Eligibility & Alignment Overview
Fresenius Medical Care's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Turnover
Total Taxonomy Eligible but Not Aligned A2 Turnover
How is Fresenius Medical Care's taxonomy-aligned revenue distributed across the EU environmental objectives?
In 2024, Fresenius Medical Care reported that its taxonomy-aligned revenue was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 1.6%
Protection and restoration of biodiversity and ecosystems: 0%
How much revenue does Fresenius Medical Care earn from selling climate-related solutions ?
In 2024, Fresenius Medical Care reported that EUR 0 of its total revenue was associated with activities contributing to the EU taxonomy climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This accounted for 0% of the company's total revenue,indicating that Fresenius Medical Carehas limited exposureon solutions that support climate action through its commercial activities.a
Insights into Fresenius Medical Care's CAPEX from Sustainable Activities
In 2024, Fresenius Medical Care reported EU Taxonomy-eligible CAPEX of EUR 14.90 million,representing 1% of its total CAPEX. Of this amount, EUR 13.20 million of Fresenius Medical Care's CAPEX was classified as EU Taxonomy-aligned, indicating that 0.9% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
How much of Fresenius Medical Care's capital expenditure (CAPEX) is eligible under the EU Taxonomy?
In 2024, Fresenius Medical Care reported that EUR 14.90 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 1% of the company's total CAPEX. Of this amount, EUR 13.20 million (0.9% of total CAPEX) was classified as Taxonomy-aligned. This means that 0.1% of Fresenius Medical Care's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Fresenius Medical Care's eligible CAPEX is aligned with the EU Taxonomy?
In 2024, Fresenius Medical Care reported that EUR 13.20 million of its CAPEX was aligned under the EU Taxonomy, representing 0.9% of its total capital investment.a
This low alignment reflects that Fresenius Medical Care is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.
Fresenius Medical Care's Eligibility & Alignment Overview
Fresenius Medical Care's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
How is Fresenius Medical Care's taxonomy-aligned CAPEX distributed across the EU environmental objectives?
In 2024, Fresenius Medical Care reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.1%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0.8%
Protection and restoration of biodiversity and ecosystems: 0%
How much Fresenius Medical Care is investing in climate-related solutions?
In 2024, Fresenius Medical Care allocated EUR 1.37 million of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.1% of the company's total capital expenditure,indicating that Fresenius Medical Carehas only marginally directed its capital expenditure toward climate-related activities, suggesting limited alignment with climate objectives.a
Insights into Fresenius Medical Care's OPEX from Sustainable Activities
In 2024, Fresenius Medical Care reported EU Taxonomy-eligible OPEX of EUR 17.80 million,representing 3% of its total operating expenses (OPEX). Of this amount, EUR 17.40 million of Fresenius Medical Care's OPEX was classified as EU Taxonomy-aligned, indicating that 2.9% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
How much of Fresenius Medical Care's operational expenditure (OPEX) is eligible under the EU Taxonomy?
In 2024, Fresenius Medical Care reported that EUR 17.80 million of its operational expenditure (OPEX) was eligible under the EU Taxonomy, representing 3% of the company's total OPEX. Of this amount, EUR 17.40 million (2.9% of total OPEX) was classified as Taxonomy-aligned. This means that 0.1% of Fresenius Medical Care's OPEX is eligible but not aligned, indicating that these expenditures either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Fresenius Medical Care's eligible OPEX is aligned with the EU Taxonomy?
In 2024, Fresenius Medical Care reported that EUR 17.40 million of its OPEX was aligned under the EU Taxonomy, representing 2.9% of its total operational expenditure.a
This low alignment reflects limited operational focus on green activities, suggesting that sustainability considerations have yet to be fully integrated into core operating processes.
Fresenius Medical Care's Eligibility & Alignment Overview
Fresenius Medical Care's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex
How is Fresenius Medical Care's taxonomy-aligned OPEX distributed across the EU environmental objectives?
In 2024, Fresenius Medical Care reported that its taxonomy-aligned operational expenditure (OPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.1%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 2.8%
Protection and restoration of biodiversity and ecosystems: 0%
How much of Fresenius Medical Care's operational budget supports climate-related solutions?
In 2024, Fresenius Medical Care allocated EUR 592,700 of its OPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.1% of the company's total OPEX,indicating that Fresenius Medical Carehas only a limited share of operational expenditure aligned with climate goals, signaling early-stage or minimal integration of climate objectives into its routine activities.a
Want Full Access to Fresenius Medical Care's EU Taxonomy Dataset?
b
b
a
b
c
a
b
a
b
a
a
b
c
a
b
c
a